Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

    Peter Pickkers, Derek C. Angus, Kristie Bass, Rinaldo Bellomo in Intensive Care Medicine (2024)

  2. Article

    Open Access

    Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

    Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud in Nature Communications (2024)

  3. Article

    Open Access

    Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

    Ilofotase alfa is a human recombinant alkaline phosphatase with reno-protective effects that showed improved survival and reduced Major Adverse Kidney Events by 90 days (MAKE90) in sepsis-associated acute kidn...

    Peter Pickkers, Derek C. Angus, Kristie Bass, Rinaldo Bellomo in Intensive Care Medicine (2024)

  4. Article

    Open Access

    Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

    Erola Pairo-Castineira, Konrad Rawlik, Andrew D. Bretherick, Ting Qi, Yang Wu in Nature (2023)

  5. Article

    Open Access

    The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury

    Recombinant erythropoietin (EPO) administered for traumatic brain injury (TBI) may increase short-term survival, but the long-term effect is unknown.

    Markus B. Skrifvars, Nora Luethi, Michael Bailey, Craig French in Intensive Care Medicine (2023)

  6. Article

    Open Access

    GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

    Critical illness in COVID-19 is an extreme and clinically homogeneous disease phenotype that we have previously shown1 to be highly efficient for discovery of genetic associations2. Despite the advanced stage of ...

    Erola Pairo-Castineira, Konrad Rawlik, Andrew D. Bretherick, Ting Qi, Yang Wu in Nature (2023)

  7. Article

    Open Access

    Oxygen targets and 6-month outcome after out of hospital cardiac arrest: a pre-planned sub-analysis of the targeted hypothermia versus targeted normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial

    Optimal oxygen targets in patients resuscitated after cardiac arrest are uncertain. The primary aim of this study was to describe the values of partial pressure of oxygen values (PaO2) and the episodes of hypoxem...

    Chiara Robba, Rafael Badenes, Denise Battaglini, Lorenzo Ball in Critical Care (2022)

  8. Article

    Open Access

    Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis

    The purpose of this work was to review and synthesise the evidence on the comparative effectiveness of neutralising monoclonal antibody (nMAB) therapies in individuals exposed to or infected with SARS-CoV-2 an...

    David McConnell, Marie Harte, Cathal Walsh, Desmond Murphy in Scientific Reports (2022)

  9. Article

    Open Access

    Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

    Up to 30% of hospitalised patients with COVID-19 require advanced respiratory support, including high-flow nasal cannulas (HFNC), non-invasive mechanical ventilation (NIV), or invasive mechanical ventilation (...

    Luis Felipe Reyes, Srinivas Murthy, Esteban Garcia-Gallo, Laura Merson in Critical Care (2022)

  10. Article

    Open Access

    Correction: Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups—practical guidance to support better practice

    Shoba Dawson, Katie Banister, Katie Biggs, Seonaidh Cotton, Declan Devane in Trials (2022)

  11. Article

    Open Access

    Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups—practical guidance to support better practice

    Randomised trials, especially those intended to directly inform clinical practice and policy, should be designed to reflect all those who could benefit from the intervention under test should it prove effectiv...

    Shoba Dawson, Katie Banister, Katie Biggs, Seonaidh Cotton, Declan Devane in Trials (2022)

  12. Article

    Open Access

    Ventilatory settings in the initial 72 h and their association with outcome in out-of-hospital cardiac arrest patients: a preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial

    The optimal ventilatory settings in patients after cardiac arrest and their association with outcome remain unclear. The aim of this study was to describe the ventilatory settings applied in the first 72 h of ...

    Chiara Robba, Rafael Badenes, Denise Battaglini, Lorenzo Ball in Intensive Care Medicine (2022)

  13. Article

    Open Access

    Correction: Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses

    Pepa Bruce, Kate Ainscough, Lee Hatter, Irene Braithwaite, Lindsay R. Berry in Trials (2022)

  14. Article

    Open Access

    Whole-genome sequencing reveals host factors underlying critical COVID-19

    Critical COVID-19 is caused by immune-mediated inflammatory lung injury. Host genetic variation influences the development of illness requiring critical care1 or hospitalization24 after infection with SARS-CoV-2...

    Athanasios Kousathanas, Erola Pairo-Castineira, Konrad Rawlik, Alex Stuckey in Nature (2022)

  15. Article

    Open Access

    Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses

    Coronavirus disease 2019 (COVID-19) has exposed the disproportionate effects of pandemics on frontline workers and the ethical imperative to provide effective prophylaxis. We present a model for a pragmatic ra...

    Pepa Bruce, Kate Ainscough, Lee Hatter, Irene Braithwaite, Lindsay R. Berry in Trials (2022)

  16. Article

    Open Access

    Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    The role of neuromuscular blocking agents (NMBAs) in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) is not fully elucidated. Therefore, we aimed to investigate in COVID-19 patie...

    Gianluigi Li Bassi, Kristen Gibbons, Jacky Y. Suen, Heidi J. Dalton in Critical Care (2022)

  17. Article

    Open Access

    Normalising comparative effectiveness trials as clinical practice

    There is a lack of high-quality evidence underpinning many contemporary clinical practice guidelines embedded in the healthcare systems, leading to treatment uncertainty and practice variation in most medical ...

    Tom Briffa, Tanya Symons, Nikolajs Zeps, Nicola Straiton in Trials (2021)

  18. Article

    Open Access

    An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients

    Heterogeneous respiratory system static compliance (CRS) values and levels of hypoxemia in patients with novel coronavirus disease (COVID-19) requiring mechanical ventilation have been reported in previous small-...

    Gianluigi Li Bassi, Jacky Y. Suen, Heidi J. Dalton, Nicole White in Critical Care (2021)

  19. Article

    Open Access

    Preparing accessible and understandable clinical research participant information leaflets and consent forms: a set of guidelines from an expert consensus conference

    In line with Good Clinical Practice and the Declaration of Helsinki, it is the investigator’s responsibility to ensure that research participants are sufficiently informed, to enable the provision of informed ...

    Eleanor Coleman, Lydia O’Sullivan, Rachel Crowley in Research Involvement and Engagement (2021)

  20. Article

    Open Access

    Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

    Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud in Nature Communications (2021)

previous disabled Page of 2